AVENUE SOLUTIONS for CUBIST PHARMACEUTICALS, INC.
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Ongoing discussions surrounding next steps for protecting and promoting incentives for the development of resistant pathogens including breakpoints Antibiotic resistance Reimbursement issues for antibiotics H.R. 4187, DISARM - Developing An Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2014 Presidents Council of Advisors on Science and Technology (PCAST) and their recent report on antibiotic resistance LPAD (Limited Population Antibacterial Drug) proposal
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH MACDONALD BARNETT | — |
| TRACY SPICER | — |
| AMY TEJRAL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.